EQT Life Sciences completed the final close of its inaugural LSP Dementia Fund, far surpassing an initial $100m fundraising goal. Also, Resilience received a $410m commitment from the Department of Defense to fund biomanufacturing and Viking cashed in on Phase I obesity data with a $250m offering.

Private Company Edition: After just seven venture capital rounds of $100m or more in January and February, five have been announced already in March, including a $200m series A round for Cargo Therapeutics, Chroma Medicine’s $135m series B financing and $112m for Noema’s series B.

CDER says a product marketed as a supplement contains three pharmaceutical ingredients, including phenformin, banned in 1978 because of the occurrence of lactic acidosis in patients. Trade group executives say warnings to 14 firms making diabetes and other disease claims demonstrate that noncompliant businesses will target more health conditions of growing concern to consumers.

CDER says a product marketed as a supplement contains three pharmaceutical ingredients, including phenformin, banned in 1978 because of the occurrence of lactic acidosis in patients. Trade group executives say warnings to 14 firms making diabetes and other disease claims demonstrate that noncompliant businesses will target more health conditions of growing concern to consumers.